ArticleThe Korean journal of internal medicine2024

Efficacy and safety of denosumab treatment for Korean patients with Stage 3b-4 chronic kidney disease and osteoporosis.

Jin Taek Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.